The findings correlate with the results from other studies that some clinicopathological factors, such as tumour site [32], tumour metastasis and metastasis site [33], comorbidity presence and number [34], CEA level [35], and tumour histopathology [36], demonstrate better prognosis in CRC patients. The gene discussed is CEACAM5; the disease is neoplasm.